Mumenthaler M, Kaeser H E, Meyer A, Hess T
J Neurol Neurosurg Psychiatry. 1979 Dec;42(12):1084-90. doi: 10.1136/jnnp.42.12.1084.
Five personal observations of an acute amnestic episode in younger individuals after intake of clioquinol are described together with three observations from the medical literature. In five of these cases the episode began after an unusually large dose, in three after a therapeutic one with a latency of about 24 hours. The clinical aspect closely resembled classical transient global amnesia but the episode after clioquinol lasted longer (24 hours to three days) and a more or less extensive retrograde amnesia persisted permanently. In one patient after three tablets of Mexase a clioquinol concentration of 12 microgram/ml in plasma was found 24 hours after the specified dose, which is an unexpectedly high concentration compared to those reported as late as 24 hours after a single equal dose of Mexase or any other clioquinol-containing preparation. Another patient had a brief relapse two years after the first episode, after a single therapeutic dose of another clioquinol preparation.
本文描述了5例年轻人服用氯碘羟喹后急性遗忘发作的个人观察结果,并结合了医学文献中的3例观察结果。其中5例发作始于超大剂量摄入后,3例发作始于治疗剂量摄入后,潜伏期约24小时。临床症状与典型的短暂性全面性遗忘极为相似,但氯碘羟喹引发的发作持续时间更长(24小时至3天),且或多或少广泛的逆行性遗忘会永久存在。一名患者服用3片美沙西后,在规定剂量24小时后血浆中氯碘羟喹浓度为12微克/毫升,与单次等量美沙西或任何其他含氯碘羟喹制剂24小时后报道的浓度相比,这一浓度意外地高。另一名患者在首次发作两年后,单次服用另一种氯碘羟喹制剂治疗剂量后出现短暂复发。